• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026

    4/13/26 9:00:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care
    Get the next $BAX alert in real time by email

    Highlights include the AAT XR, the next-generation version of the Allen Advance Table designed to support surgical teams across a range of spine procedures, and the Dynamo Series smart stretcher

    Baxter International Inc. (NYSE:BAX), a global medtech leader, is highlighting recent additions to its Global Surgical Solutions and Patient Support Systems portfolios, as well as its broad Advanced Surgery portfolio of hemostatic and sealing agents, at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo, taking place April 11-14, 2026 in New Orleans. New offerings include the AAT XR spine surgical table and the Dynamo Series smart stretcher, both on display at Baxter booth #1319.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260407211404/en/

    AAT XR, the new spine surgical table / Baxter

    AAT XR, the new spine surgical table / Baxter

    "Innovation at Baxter is shaped by the realities of how care is delivered today," said James Teaff, president of Care & Connectivity Solutions at Baxter. "Through close collaboration with healthcare professionals, we consistently evolve our portfolio to help enhance efficiency and support safer care across hospital settings. The new portfolio additions we're exhibiting at AORN reflect our commitment to driving meaningful improvements that help reduce the burden on care teams while supporting improved patient outcomes."

    Research shows that manual patient rotation during spine surgery is a time-intensive process that increases physical strain on operating room staff.1 Designed to support safe, quick and easy patient maneuvering during spine surgery, the AAT XR allows surgical teams to rotate the table at 180-degrees2 without needing to remove the patient from the table, with fast lock and unlock functions3 supporting smoother transitions. Surgical teams can control the AAT XR at two different points (head column and remote control)4 to support easier manipulation and patient positioning. Additional enhancements include an increased weight capacity of up to 650 pounds5 to accommodate a broader range of patient sizes, a high performance lithium‑ion battery6 that delivers a longer lifespan compared to traditional lead acid batteries and a lower minimum table height of 22 inches7 to improve surgical access. Together, these capabilities help streamline workflows, enhance efficiency and optimize the time spent in the operating room. The AAT XR is expected to be available in the United States early in the second half of 2026, with select geographic expansion planned later this year.

    The Dynamo Series smart stretcher, the latest innovation in Baxter's leading portfolio of smart beds, surfaces and connected care solutions, is currently available in the U.S. Designed with input from frontline clinicians, the Dynamo Series intends to help address common challenges care teams face in high-pressure settings,8 including reducing the need for patient transfers and simplifying patient positioning across a range of procedures.9 The Dynamo Series is intended to help enhance the care team experience, address patient falls10 and improve patient comfort.11

    Baxter is also showcasing at AORN its broad Advanced Surgery portfolio of hemostatic and sealing agents that effectively work to stop bleeding in a variety of anatomies to help lower bleeding-related complications and reduce overall costs. To learn more about Baxter's Advanced Surgery portfolio, visit https://advancedsurgery.baxter.com/.

    About Baxter

    At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician's office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on our unmatched portfolio of connected solutions, medical devices, and advanced injectable technologies. Approximately, 37,500 Baxter team members live our enduring Mission: to Save and Sustain Lives. Together, we are redefining how care is delivered to make a greater impact today, tomorrow, and beyond. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.

    RX Only. For safe and proper use of these devices, please refer to the full Instructions for Use.

    This release includes forward-looking statements concerning potential benefits associated with the AAT XR, Allen and the Dynamo Series. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand for and market acceptance for new and existing products; product development risks; inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of natural disasters, public health crises and epidemics/pandemics, regulatory actions or otherwise); satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter's most recent filing on Form 10-K and Form 10-Q and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.

    Baxter, Allen and Dynamo Series are trademarks of Baxter International Inc. or its subsidiaries.

    1 Shriver MF, et al. Lumbar spine surgery positioning complications: a systematic review. Neurosurgical Focus, 2015;39(4):E16.

    HoverTech International, 2022 – Perioperative Spinal Surgery Prone Positioning

    2 AAT XR IFU 224132 Page 1, Intended Use

    3 Data on file at Baxter International Inc. Articulation Timing Angle Verification script.

    4 AAT XR IFU 224132 Pages 4-5

    5 XR IFU 224132 Page 48, "650lbs (295kg) is the maximum patient weight with the flat top installed" AAT

    6 Supporting information on file at Baxter International Inc., March 2026

    7 AAT XR IFU 224132 Page 48

    8 Data on file at Baxter International Inc. External Market Research Report. December 8, 2025.

    9 Dynamo Series Stretcher IFU. 220146 rev 1. December 19, 2025

    10 Carle Health. Utilization of Fall Prevention Technologies in Hospital Beds. Poster Presented September 2025.

    11 Wiggermann et al., (2017). What Bed Size Does a Patient Need? The Relationship Between Body Mass Index and Space Required to Turn in Bed. Nursing Research, 66(6), 483-489.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260407211404/en/

    Media Contact:

    Sandrine Nadaud, (224) 948-5353

    media@baxter.com

    Investor Contact:

    Kevin Moran, (224) 948-3085

    global_corp_investor_relations@baxter.com

    Get the next $BAX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BAX

    DatePrice TargetRatingAnalyst
    10/31/2025Buy → Hold
    Argus
    8/4/2025$25.00Buy → Hold
    Stifel
    8/1/2025$25.00Buy → Neutral
    Goldman
    2/26/2025$42.00Buy
    Goldman
    2/24/2025Hold → Buy
    Argus
    2/20/2025$39.00Overweight
    Barclays
    7/15/2024$39.00 → $30.00Equal-Weight → Underweight
    Morgan Stanley
    5/30/2024$36.00Neutral
    Goldman
    More analyst ratings

    $BAX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Baxter downgraded by Argus

    Argus downgraded Baxter from Buy to Hold

    10/31/25 8:47:22 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter downgraded by Stifel with a new price target

    Stifel downgraded Baxter from Buy to Hold and set a new price target of $25.00

    8/4/25 8:18:58 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter downgraded by Goldman with a new price target

    Goldman downgraded Baxter from Buy to Neutral and set a new price target of $25.00

    8/1/25 8:11:11 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026

    Highlights include the AAT XR, the next-generation version of the Allen Advance Table designed to support surgical teams across a range of spine procedures, and the Dynamo Series smart stretcher Baxter International Inc. (NYSE:BAX), a global medtech leader, is highlighting recent additions to its Global Surgical Solutions and Patient Support Systems portfolios, as well as its broad Advanced Surgery portfolio of hemostatic and sealing agents, at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo, taking place April 11-14, 2026 in New Orleans. New offerings include the AAT XR spine surgical table and the Dynamo Series smart stretcher, both on display

    4/13/26 9:00:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors

    Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its first-quarter 2026 financial results on Thursday, April 30, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I946023356 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. About Baxter At Baxter, we are everywhere healthcare happens – and everyw

    4/8/26 4:15:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings

    New system offers a standardized and simplified alternative to traditional handwritten line labeling that supports safer medication administration Solution aims to streamline nursing workflow, helping to save clinician time and reduce likelihood of medication errors related to IV line labeling inconsistencies Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and platforms, today debuted the IV Verify Line Labeling System, an automated solution, at the 2026 American Organization for Nursing Leadership Conference. The IV Verify system is designed to streamline nursing workflows, save clinician time and support safer medication administration at the bedsid

    3/30/26 8:30:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Foster Julie

    3 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    4/9/26 4:14:45 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Wallace Steven P.

    3 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    4/9/26 4:06:31 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Teaff James

    3 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    4/9/26 4:05:34 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Financials

    Live finance-specific insights

    View All

    Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors

    Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its first-quarter 2026 financial results on Thursday, April 30, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I946023356 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. About Baxter At Baxter, we are everywhere healthcare happens – and everyw

    4/8/26 4:15:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter Reports Fourth-Quarter 2025 Results

    Fourth-quarter sales from continuing operations of $2.97 billion increased 8% on a reported basis and 3% on an operational basis1,2 Fourth-quarter U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($2.01); adjusted diluted EPS from continuing operations of $0.44 Company advances ongoing board of directors refreshment Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter of 2025. "While we delivered sales growth across all segments, our fourth-quarter results did not meet our expectations, underscoring the importance of our focus on driving continuous improvement across the enterprise," said And

    2/12/26 7:15:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors

    Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its fourth-quarter 2025 financial results on Thursday, February 12, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I81994118 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. About Baxter At Baxter, we are everywhere healthcare happens – and eve

    1/21/26 5:00:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Leadership Updates

    Live Leadership Updates

    View All

    Baxter Appoints Andrew Hider Chief Executive Officer

    Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment commitments. Brent Shafer, who has served as chair and interim CEO since February 2025, will then transition to independent chair of the Baxter Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250706840140/en/Andrew Hider Appointed Baxter's Next CEO Since 2017, Mr. Hider has served as

    7/7/25 8:35:00 AM ET
    $ATS
    $BAX
    Industrial Machinery/Components
    Industrials
    Medical/Dental Instruments
    Health Care

    Amerant Bancorp Announces Appointment of Two New Board Members

    Amerant Bancorp Inc. (NYSE:AMTB) ("Amerant" or "the Company") and its subsidiary, Amerant Bank, N.A. (the "Bank"), today announced the appointment of two accomplished executives, Patricia "Patty" Morrison and Jack Kopnisky, to the Board of Directors of the Company and the Bank. Their addition reflects the Company's continued commitment to strategic growth and further strengthening of the Board of Directors and executive management. "We are delighted to welcome both Patty and Jack to our Board of Directors," said Jerry Plush, Chairman and CEO of Amerant and the Bank. "Patty's deep technology leadership and extensive board expertise, paired with Jack's enviable experience in leading high pe

    6/24/25 9:20:00 AM ET
    $AMTB
    $BAX
    $WBS
    Major Banks
    Finance
    Medical/Dental Instruments
    Health Care

    PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

    Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert "Bob" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthca

    3/11/25 7:05:00 AM ET
    $BAX
    $BMRN
    $EMBC
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Medical Specialities

    $BAX
    SEC Filings

    View All

    SEC Form DEFA14A filed by Baxter International Inc.

    DEFA14A - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    3/23/26 8:52:56 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14A filed by Baxter International Inc.

    DEF 14A - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    3/23/26 8:51:59 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter International Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    3/19/26 4:45:33 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Baxter International Inc.

    SC 13G/A - BAXTER INTERNATIONAL INC (0000010456) (Subject)

    11/13/24 1:08:27 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Baxter International Inc. (Amendment)

    SC 13G/A - BAXTER INTERNATIONAL INC (0000010456) (Subject)

    2/13/24 5:00:53 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Baxter International Inc.

    SC 13G - BAXTER INTERNATIONAL INC (0000010456) (Subject)

    2/13/24 1:08:57 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care